CTI BioPharma
Fludarabine Phosphate(CTI BioPharma)은 B-cell Acute Lymphoblastic Leukemia 표적 치료제로, Leukemia; Lymphoma 영역에서 개발·상용화 중입니다. 작용기전: targeted metabolomic profiling of plasma samples was conducted to identify significantly altered metabolites and enriched metabolic pathway. Phase 3 후기 임상 단계입니다. 대표 임상 효능: ORR 59% (ClinicalTrials.gov NCT00602459). PK: t½ 6 h. 차별점: novel drug combination of fludarabine phosphate with aspirin as a potential cancer therapy strategy.
B-cell Acute Lymphoblastic Leukemia
Leukemia; Lymphoma
Recruiting
gene therapy approach to cancer treatment involving E
vedotin, polatuzumab vedotin, enfortumab vedoti
lipid nanoparticles (LNPs) using species-agnostic DNA barcoding in tumor-bearing mice
novel drug combination of fludarabine phosphate with aspirin as a potential cancer therapy strategy
targeted metabolomic profiling of plasma samples was conducted to identify significantly altered metabolites and enriched metabolic pathway
cytokine release syndrome after chimeric antigen receptor T cell therapy: A case report
apoptosis via the intrinsic pathway
biomarker study in HLA-haploidentical hematopoietic cell transplant recipients
차트 로드 중…
임상시험이 많습니다. 임상시험 탭에서 Phase/Status 필터·검색을 사용하세요.
수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다.
CTI BioPharma
Fludarabine Phosphate(CTI BioPharma)은 B-cell Acute Lymphoblastic Leukemia 표적 치료제로, Leukemia; Lymphoma 영역에서 개발·상용화 중입니다. 작용기전: targeted metabolomic profiling of plasma samples was conducted to identify significantly altered metabolites and enriched metabolic pathway. Phase 3 후기 임상 단계입니다. 대표 임상 효능: ORR 59% (ClinicalTrials.gov NCT00602459). PK: t½ 6 h. 차별점: novel drug combination of fludarabine phosphate with aspirin as a potential cancer therapy strategy.
B-cell Acute Lymphoblastic Leukemia
Leukemia; Lymphoma
Recruiting
gene therapy approach to cancer treatment involving E
vedotin, polatuzumab vedotin, enfortumab vedoti
lipid nanoparticles (LNPs) using species-agnostic DNA barcoding in tumor-bearing mice
novel drug combination of fludarabine phosphate with aspirin as a potential cancer therapy strategy
targeted metabolomic profiling of plasma samples was conducted to identify significantly altered metabolites and enriched metabolic pathway
cytokine release syndrome after chimeric antigen receptor T cell therapy: A case report
apoptosis via the intrinsic pathway
biomarker study in HLA-haploidentical hematopoietic cell transplant recipients
차트 로드 중…
임상시험이 많습니다. 임상시험 탭에서 Phase/Status 필터·검색을 사용하세요.
수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다.